The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis
- 1 September 1996
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 125 (2) , 217-229
- https://doi.org/10.1016/0021-9150(96)05880-7
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- A simple fluorometric assay for lipoperoxide in blood plasmaPublished by Elsevier ,2004
- Probucol Treatment Decreases Serum Concentrations of Diet-Derived AntioxidantsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1994
- Susceptibility of low-density lipoproteins to oxidation in coronary bypass patientsThe Lancet, 1992
- Oxidative status of lipoproteins in coronary disease patientsAmerican Heart Journal, 1992
- β-Carotene inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- High-density lipoprotein inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status reportThe American Journal of Cardiology, 1988
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986